Results 1 to 10 of about 1,264,036 (325)
Oral Diseases(2011)18, 1–15This review focuses on the prominent etiological and pathogenetic aspects of inflammatory bowel disease (IBD), with particular attention being paid to the mucosal immune response to commensal micro‐organisms in health and disease. Pathogenetic implications for target therapy will also be discussed.
E. Szigethy, L. McLafferty, A. Goyal
semanticscholar +7 more sources
Inflammatory Bowel Disease. [PDF]
Contains fulltext : 296499.pdf (Publisher’s version ) (Open Access)
L. Bruner, Ann Marie White, S. Proksell
semanticscholar +4 more sources
Extracts of Feijoa Inhibit Toll-Like Receptor 2 Signaling and Activate Autophagy Implicating a Role in Dietary Control of IBD [PDF]
Inflammatory bowel disease (IBD) is a heterogeneous chronic inflammatory disease affecting the gut with limited treatment success for its sufferers.
A Asea+39 more
core +25 more sources
Inflammatory bowel disease [PDF]
Inflammatory bowel diseases (IBDs) encompass ulcerative colitis, Crohn's disease, and indeterminate colitis, all of which are characterized by remission and exacerbation of gastrointestinal symptoms, and a variety of extraintestinal manifestations including those affecting the oral cavity.
Clara, Abraham, Judy H, Cho
+8 more sources
Inflammatory bowel disease [PDF]
Scandinavian researchers have contributed to the present understanding of inflammatory bowel disease (IBD). Important epidemiological data and family risk factors have been reported from all the Nordic countries, original twin studies mainly from Denmark and Sweden, and relationships to cancer and surgery mostly from Sweden.
Vatn, Morten H, Sandvik, Arne Kristian
openaire +5 more sources
Pathophysiology of Inflammatory Bowel Disease: Innate Immune System
Inflammatory bowel disease (IBD), comprising Crohn’s disease (CD) and ulcerative colitis (UC), is a heterogeneous state of chronic intestinal inflammation with no exact known cause.
Angela Sáez+4 more
semanticscholar +1 more source
BACKGROUND The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of Inflammatory Bowel Diseases (IOIBD) has proposed treatment-targets in 2015 for adult IBD patients.
D. Turner+19 more
semanticscholar +1 more source
Inflammatory bowel diseases, including Crohn’s disease and ulcerative colitis, is a chronic relapsing gastrointestinal inflammatory disease mediated by dysregulated immune responses to resident intestinal microbiota.
Mengyu Zheng+8 more
semanticscholar +1 more source
Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels [PDF]
Background Inflammatory bowel disease (IBD), is a debilitating group of chronic diseases including Crohn’s Disease (CD) and ulcerative colitis (UC), which causes inflammation of the gut and affects millions of people worldwide.
Alam, Mohammad T.+5 more
core +1 more source
The two most important bacterial phyla in the gastrointestinal tract, Firmicutes and Bacteroidetes, have gained much attention in recent years. The Firmicutes/Bacteroidetes (F/B) ratio is widely accepted to have an important influence in maintaining ...
S. Stojanov, A. Berlec, B. Strukelj
semanticscholar +1 more source